<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02777957</url>
  </required_header>
  <id_info>
    <org_study_id>SilesianCHD</org_study_id>
    <nct_id>NCT02777957</nct_id>
  </id_info>
  <brief_title>Predictors of Pulmonary Hypertension in Patients With Advanced Lung Diseases</brief_title>
  <official_title>Predictors and Survival in Pulmonary Hypertension Associated With Severe Lung Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Silesian Centre for Heart Diseases</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Silesian Centre for Heart Diseases</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      First, the aim of the study was to evaluate the usefulness of echocardiographic parameters
      for detecting pulmonary hypertension (PH) in patients with advanced lung disease referred for
      lung transplantation. Second, to assess the prevalence of PH and to identify which
      hemodynamic, echocardiographic, pulmonary functional test, exercise capacity and biochemical
      parameters (especially NT-proBNP) have an impact on survival in a cohort of patients with
      severe lung diseases referred for lung transplantation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Survival after the initial right heart catheterization (RHC) measurements</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survival to lung transplantation or the end of the observation period after the initial right heart catheterization (RHC) measurement</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>mPAP ≥ 25 mmHg</arm_group_label>
    <description>mean pulmonary artery pressure (mPAP) ≥ 25 mmHg (37 patients)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>mPAP &lt; 25 mmHg</arm_group_label>
    <description>mean pulmonary artery pressure (mPAP) &lt; 25 mmHg (28 patients).</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients with advanced lung diseases referred for lung transplantation. All
        patients underwent examinations as potential candidates for lung transplantation, including
        laboratory testing, pulmonary function tests, exercise capacity, echocardiography
        examination, and right heart catheterization. Evaluation for lung transplantation was
        performed during clinically stable periods in all patients on optimal medical and oxygen
        therapy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  advanced lung disease

          -  qualification for lung transplantation

          -  written informed consent

          -  pulmonary capillary wedge pressure &lt; 15 mmHg

        Exclusion Criteria:

          -  cancer,

          -  history of idiopathic pulmonary hypertension,

          -  primary valvular heart diseases,

          -  coronary artery disease,

          -  collagen vascular disease,

          -  history or evidence of left ventricular dysfunction,

          -  atrial fibrillation,

          -  increased liver enzyme levels ( 3 times the upper laboratory limit),

          -  renal dysfunction (estimated glomerular filtration rate &lt; 60 ml/min/1.73m2)

          -  patients who didn't write the personal informed consent

          -  any specific therapy for PH.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jolanta Nowak, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>3rd Department of Cardiology, Silesian Centre for Heart Diseases</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mariusz Gasior, Prof., PhD</last_name>
    <role>Study Chair</role>
    <affiliation>3rd Department of Cardiology, Silesian Centre for Heart Diseases</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Slawomir Zeglen, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Departament of Cardiac Surgery and Transplantology, Silesian Centre for Heart Diseases</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jacek Wojarski, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Departament of Cardiac Surgery and Transplantology, Silesian Centre for Heart Diseases</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jolanta Nowak, MD, PhD</last_name>
    <email>nowjola@wp.pl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Silesian Centre for Heart Diseases</name>
      <address>
        <city>Zabrze</city>
        <state>Silesia</state>
        <zip>41-800</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jolanta Nowak, MD, PhD</last_name>
      <email>nowjola@wp.pl</email>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2016</study_first_submitted>
  <study_first_submitted_qc>May 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 19, 2016</study_first_posted>
  <last_update_submitted>May 18, 2016</last_update_submitted>
  <last_update_submitted_qc>May 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Silesian Centre for Heart Diseases</investigator_affiliation>
    <investigator_full_name>Jolanta Nowak</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Echocardiography</keyword>
  <keyword>Lung Transplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

